Skip to main content

Peer Review reports

From: Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients

Original Submission
5 Nov 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Jan 2021 Reviewed Reviewer Report
22 Feb 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 3
22 Feb 2021 Submitted Manuscript version 3
27 Feb 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 4
27 Feb 2021 Submitted Manuscript version 4
2 Mar 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 5
2 Mar 2021 Submitted Manuscript version 5
4 Mar 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 6
4 Mar 2021 Submitted Manuscript version 6
1 Sep 2021 Reviewed Reviewer Report
7 Sep 2021 Reviewed Reviewer Report - Sanjay Addla
2 Nov 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 7
2 Nov 2021 Submitted Manuscript version 7
9 Nov 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 8
9 Nov 2021 Submitted Manuscript version 8
15 Nov 2021 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 9
15 Nov 2021 Submitted Manuscript version 9
15 Dec 2021 Reviewed Reviewer Report
10 Feb 2022 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 10
10 Feb 2022 Submitted Manuscript version 10
28 Feb 2022 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 11
28 Feb 2022 Submitted Manuscript version 11
3 Mar 2022 Author responded Author comments - ilknur Alsan Cetin
Resubmission - Version 12
3 Mar 2022 Submitted Manuscript version 12
17 Oct 2022 Reviewed Reviewer Report
Resubmission - Version 13
Submitted Manuscript version 13
Publishing
20 Oct 2022 Editorially accepted
15 Nov 2022 Article published 10.1186/s12894-022-01125-1

You can find further information about peer review here.

Back to article page